S. Bota

Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01)

Fabrice Barlési, R. Gervais, H. Léna et al. · Annals of Oncology · 2011 · 245 citations · Full text

Medicine, Gfpc 07-01, Bronchial Neoplasm +7

Follow-up of Bronchial Precancerous Lesions and Carcinoma <i>in Situ</i> Using Fluorescence Endoscopy

S. Bota, J.B. Auliac, Christophe Paris et al. · American Journal of Respiratory and Critical Care Medicine · 2001 · 209 citations

Interventional Pulmonology, Severe Dysplasia, Oncologic Imaging +21

Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial

Denis Moro‐Sibilot, Nathalie Cozic, M. Pérol et al. · Annals of Oncology · 2019 · 192 citations · Full text

Medicinal Chemistry, Ros1-positive Nsclc, Medicine +4

Occupational and nonoccupational factors associated with high grade bronchial pre-invasive lesions

Christophe Paris, Jacques Bénichou, S. Bota et al. · European Respiratory Journal · 2003 · 31 citations · Full text

Asthma, Pulmonary Care, Nonoccupational Factors +16

Fatal haemoptysis in a case of lymphomatoid granulomatosis treated with rituximab

S. Jaffré, Fabrice Jardin, S. Dominique et al. · European Respiratory Journal · 2006 · 17 citations · Full text

Last Rituximab Administration, Lymphoid Neoplasia, Granulocyte +11